Popular on eTradeWire
- Zorzal Inversiones Tecnológicas completed a purchase of shares of Arkano Software - 136
- Multi-Award Winning B.Slade to Debut in Las Vegas at Iconic Westgate Resort & Casino; The B.Slade Experience (BSX) — May 3, 2025 - 115
- SSATI Completes Acquisition of Invex Technology Solutions and ITIC Corporation's Government Support Services - 115
- FoodNiche Health Forum Announce Awards Recognizing Global Leaders Enhancing Health In Communities Through Food Initiatives & Innovation - 114
- Dizengoff and Yost Launch Digital Sign in Hammonton NJ - 110
- Matthew Cossolotto, Author of the Forthcoming Harness Your PromisePower With Jack Canfield Foreword, Offers Model "Make a Promise Day" Proclamation - 110
- Costa Rica's Rainy Season Brings a Surge in Sportfishing Action and Travel Deals - 109
- Cloudsyte to Debut New Resilience & Sustainability Enhancements at SSDN 2025 Annual Meeting - 107
- Extra! Extra! Read All About It! Phoenix-Lotus Creative Enterprise Celebrates Mom with 50% Off & La - 107
- Arizona Technology Council Appoints Cepand Alizadeh as Government Relations Specialist - 105
Similar on eTradeWire
- Solomon Eye Appoints Dr. Nancy Draskovic as Clinical Director of Ocular Surface Disease
- Gupta Homoeo Clinic Launches 50% Off Online Consultation Offer to Help Patients Across the Globe Access Expert Homoeopathy Care
- The Wuhan Lab Wasn't Just Certified — It Was Enabled: How U.S. Accreditation Helped Build a Global Crisis
- CEO Selected to Present at Wall Street Conference on May 21, 2025 for Suicidal Depression / PTSD: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
- Phoenix Implant Clinic Introduces Upfront Cost Page to Strengthen Patient Trust
- Pregis Expands its Curbside-Recyclable Paper Packaging Portfolio with White EasyPack GeoTerra
- Advanced Dental Techniques Recognized as a Top Family Dentist for 2024
- Solomon Eye Physicians & Surgeons announces appointment of Ann Reiling as Chief Operations Officer
- Why IVF Professionals Trust Cryolab for Liquid Nitrogen Handling
- Highland Instruments Receives START Stage I Grant Award From MassVentures
Precision Antibody's Founder and CEO to Speak at the 2025 Drug Discovery Strategic Summit Boston
eTradeWire News/10801792
COLUMBIA, Md. - eTradeWire -- Columbia, MD—The founder, Dr. Jun Hayashi, and the CEO, Dr. Ginette Serrero, of Precision Antibody, a leading service provider for custom monoclonal antibody development, will be the chief speakers at "Drug Discovery Strategic Summit (DDSS) 2025" that will take place between April 30 - May 1 2025 in Boston, Massachusetts.
The passionate leaders and innovators from the pharmaceutical and biotech sector share their visionary thoughts at the Drug Discovery Strategic Summit. The latest advancements in drug discovery, current challenges, preclinical development, and translational science will be the focus topics of the summit.
Both Dr. Jun and Dr. Ginette will shed light on the vital role of high-affinity and high-specificity monoclonal antibodies in speeding the process of drug discovery and improvements in translational science. They will also share key insights from their two decades of experience in the field of antibody discovery and its development.
"The mission of Precision Antibody is to make reliable antibodies that help researchers carry forward the innovation and advancements," said Dr. Serrero. "It is my pleasure that I am honored to speak at DDSS, a global platform for conversation on therapeutic research," said Dr. Hayashi.
More on eTradeWire News
About Precision Antibody
The company has more than two decades of experience in providing personalized services for monoclonal and polyclonal antibody development. It was founded in 2000, and now it is a global leader in delivering solutions for therapeutic and research purposes. It is also equipped to tackle antibody requirements for oncology, immunology, and regenerative medicine. The deal with academic research centers and worldwide pharma companies.
Media Contact:
Precision Antibody
Dr. Jun Hayashi
President
Phone: 410-884-4100
Email: info@precisionantibody.com
Website: www.precisionantibody.com
Event Details:
Drug Discovery Strategic Summit (DDSS)
Dates: April 30 – May 1, 2025
Venue: Boston, MA
Event Website: https://ddss.agilefalconsg.com/
The passionate leaders and innovators from the pharmaceutical and biotech sector share their visionary thoughts at the Drug Discovery Strategic Summit. The latest advancements in drug discovery, current challenges, preclinical development, and translational science will be the focus topics of the summit.
Both Dr. Jun and Dr. Ginette will shed light on the vital role of high-affinity and high-specificity monoclonal antibodies in speeding the process of drug discovery and improvements in translational science. They will also share key insights from their two decades of experience in the field of antibody discovery and its development.
"The mission of Precision Antibody is to make reliable antibodies that help researchers carry forward the innovation and advancements," said Dr. Serrero. "It is my pleasure that I am honored to speak at DDSS, a global platform for conversation on therapeutic research," said Dr. Hayashi.
More on eTradeWire News
- Mighty Hero Homes Hosts Benefit Concert, Presented by State Farm™ to Help End Veteran Homelessness
- Elevate Your Retreat: at Southern Utah Retreats
- IEI Launches IMB-AM5 microATX with AMD Ryzen™ 7000/8000G/9000 PHX1 for Industrial Edge AI
- Westchester Soccer Club Hosts Richmond Kickers FC at The Stadium at Memorial Field Sunday
- Beyond the Surface: Howson Inspections—Where Every Beam Tells the Truth
About Precision Antibody
The company has more than two decades of experience in providing personalized services for monoclonal and polyclonal antibody development. It was founded in 2000, and now it is a global leader in delivering solutions for therapeutic and research purposes. It is also equipped to tackle antibody requirements for oncology, immunology, and regenerative medicine. The deal with academic research centers and worldwide pharma companies.
Media Contact:
Precision Antibody
Dr. Jun Hayashi
President
Phone: 410-884-4100
Email: info@precisionantibody.com
Website: www.precisionantibody.com
Event Details:
Drug Discovery Strategic Summit (DDSS)
Dates: April 30 – May 1, 2025
Venue: Boston, MA
Event Website: https://ddss.agilefalconsg.com/
Source: Precision Antibody
Filed Under: Medical
0 Comments
Latest on eTradeWire News
- Why Traditional PR Is Failing Authors—And What Works Instead
- Driving Successful Lives Sponsors Magical Fundraiser Night at White Lake Presbyterian Church
- Queer Horror Poetry Collection Monsters in the Closet Now Available in Paperback
- Metal Maniacs Launches New Website to Enhance Customer Experience and Show Metal Roofing Expertis
- Comedy Legend Bob Zany Headlines Delirious Comedy Club on Fremont Street
- Leading by Example, The Swig Company Continues to Push Toward Net Zero
- Sweet Tea Home Care™ Brings Southern Warmth and Professional In-Home Support to Birmingham, AL
- Chosen Celebrates 10 Years with Launch of Mobile Family Closet Fundraising Campaign
- Solomon Eye Appoints Dr. Nancy Draskovic as Clinical Director of Ocular Surface Disease
- Tee Up for Chosen: Charity Golf Outing to Support Foster, Adoptive & Kinship Families
- 150% Increase in Fiscal Q2 Sales vs Previous Year to $750,000; Continuous Record Quarters & Profitability for Homebuilding Product: Innovative Designs
- American Property Group Announces $2.1M Sale of Freestanding Restaurant on US 41 in Sarasota
- Arm In Arm Takes Home The Bronze
- Retail Displays and Fixturing are Going Cord Free
- New Comprehensive Directory Website Launches to Connect UK Consumers with Local Vape Shops
- Forum Named One of the Best Places to Work in Illinois—Five Years in a Row
- Northern Polytunnels Launches Strongest Single Span Polytunnel Yet
- RXM Creative and NOUKK Win Gold at ADC New York Festival for Brand Identity
- Jonathan Grode Named on 2025 Pennsylvania Super Lawyers List for Immigration Law
- Hackers Rigging Court Wins Compromise Unrelated Federal Sting Ops Exposing Massive Judicial Cyber Crisis